ArticleAlimentary pharmacology & therapeutics2020

Letter: ACE2, IBD and COVID-19-why IBD patients may be at reduced risk of COVID-19.

Ralley E Prentice et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.